Literature DB >> 15379731

Genetic elements carrying macrolide efflux genes in streptococci.

Gianni Pozzi1, Francesco Iannelli, Marco R Oggioni, Maria Santagati, Stefania Stefani.   

Abstract

Type M resistance to macrolides in Streptococcus pyogenes and Streptococcus pneumoniae is associated to the presence of macrolide efflux genes (mef). These genes are carried by 3 very conserved chromosomal genetic elements: (i) "mega", 5.5 kb, typical of S. pneumoniae, carries mef(E), can insert at different sites in the bacterial chromosome and in other genetic elements, does not have genes encoding putative recombinases or transposases, and it is not conjugative; (ii) Tn1207.3, 54, 52 kb, typical of S. pyogenes, carries mef(A), it integrates at a single specific site in the bacterial chromosome, carries 3 ORFs encoding for putative recombinases, it is transferred by conjugation among different streptococcal species, and its genome resembles that of a bacteriophage; (iii) Tn1207.1, 7.2 kb, is a defective form of Tn1207.3 found in a clonal population of S. pneumoniae, it carries mef(A), it integrates at a single specific site in the bacterial chromosome (the same of Tn1207.3), and it is not conjugative.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15379731     DOI: 10.2174/1568005043340641

Source DB:  PubMed          Journal:  Curr Drug Targets Infect Disord        ISSN: 1568-0053


  14 in total

1.  Trends in resistance to penicillin and erythromycin of invasive pneumococci in Portugal.

Authors:  R Dias; M Caniça
Journal:  Epidemiol Infect       Date:  2007-08-16       Impact factor: 2.451

2.  Erythromycin resistance and genetic elements carrying macrolide efflux genes in Streptococcus agalactiae.

Authors:  José María Marimón; Adoración Valiente; María Ercibengoa; José M García-Arenzana; Emilio Pérez-Trallero
Journal:  Antimicrob Agents Chemother       Date:  2005-12       Impact factor: 5.191

Review 3.  Xenobiotic efflux in bacteria and fungi: a genomics update.

Authors:  Ravi D Barabote; Jose Thekkiniath; Richard E Strauss; Govindsamy Vediyappan; Joe A Fralick; Michael J San Francisco
Journal:  Adv Enzymol Relat Areas Mol Biol       Date:  2011

4.  Expression of the mef(E) gene encoding the macrolide efflux pump protein increases in Streptococcus pneumoniae with increasing resistance to macrolides.

Authors:  Aleksandra K Wierzbowski; Dave Boyd; Michael Mulvey; Daryl J Hoban; George G Zhanel
Journal:  Antimicrob Agents Chemother       Date:  2005-11       Impact factor: 5.191

Review 5.  The use of macrolides in treatment of upper respiratory tract infections.

Authors:  Aleksandra K Wierzbowski; Daryl J Hoban; Tamiko Hisanaga; Mel DeCorby; George G Zhanel
Journal:  Curr Allergy Asthma Rep       Date:  2006-03       Impact factor: 4.806

6.  The Use of Macrolides in Treatment of Upper Respiratory Tract Infections.

Authors:  Aleksandra K Wierzbowski; Daryl J Hoban; Tamiko Hisanaga; Mel Decorby; George G Zhanel
Journal:  Curr Infect Dis Rep       Date:  2005-05       Impact factor: 3.725

7.  M.SpyI, a DNA methyltransferase encoded on a mefA chimeric element, modifies the genome of Streptococcus pyogenes.

Authors:  Chad W Euler; Patricia A Ryan; Judith M Martin; Vincent A Fischetti
Journal:  J Bacteriol       Date:  2006-11-03       Impact factor: 3.490

8.  Molecular epidemiology of macrolide and tetracycline resistances in commensal Gemella sp. isolates.

Authors:  Paula Cerdá Zolezzi; Pilar Goñi Cepero; Joaquim Ruiz; Leticia Millán Laplana; Carmen Rubio Calvo; Rafael Gómez-Lus
Journal:  Antimicrob Agents Chemother       Date:  2007-02-05       Impact factor: 5.191

9.  Saturated alanine scanning mutagenesis of the pneumococcus competence stimulating peptide identifies analogs that inhibit genetic transformation.

Authors:  Chaohui Duan; Luchang Zhu; Ying Xu; Gee W Lau
Journal:  PLoS One       Date:  2012-09-13       Impact factor: 3.240

10.  Inhibition of competence development, horizontal gene transfer and virulence in Streptococcus pneumoniae by a modified competence stimulating peptide.

Authors:  Luchang Zhu; Gee W Lau
Journal:  PLoS Pathog       Date:  2011-09-01       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.